Abstract | BACKGROUND: AIM: The aim of this study is to evaluate clusterin as a marker for evaluating diagnosis and metastasis potential of viral-related HCC. METHODS: RESULTS: Serum clusterin levels were significantly increased in patients with HCC. Serum clusterin was highly increased in patients with poorly differentiated tumor, capsular infiltration, portal vein invasion and lymph node infiltration. Receiver operator characteristic curve showed that clusterin had a greater area under curve value (0.95) than that of alpha fetoprotein (0.85). At cutoff value of 128 μg/mL, serum clusterin yielded (90%) sensitivity and (87%) specificity for predicting HCC. CONCLUSION: We concluded that clusterin is a promising useful marker for diagnosis of HCC. Clusterin might be deemed as a useful marker for predicting the progression and metastasis potential of HCC.
|
Authors | Abeer M Nafee, Heba F Pasha, Salah M Abd El Aal, Naglaa A Mostafa |
Journal | Clinical biochemistry
(Clin Biochem)
Vol. 45
Issue 13-14
Pg. 1070-4
(Sep 2012)
ISSN: 1873-2933 [Electronic] United States |
PMID | 22580393
(Publication Type: Journal Article)
|
Copyright | Copyright © 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- AFP protein, human
- Biomarkers, Tumor
- CLU protein, human
- Clusterin
- alpha-Fetoproteins
|
Topics |
- Area Under Curve
- Biomarkers, Tumor
(blood)
- Blood Chemical Analysis
(methods)
- Carcinoma, Hepatocellular
(diagnosis, epidemiology, virology)
- Case-Control Studies
- Clusterin
(blood)
- Enzyme-Linked Immunosorbent Assay
- Female
- Hepacivirus
(pathogenicity)
- Hepatitis, Chronic
(epidemiology, pathology, virology)
- Humans
- Liver Cirrhosis
(blood, epidemiology)
- Male
- Middle Aged
- Neoplasm Metastasis
(pathology)
- Portal Vein
(pathology)
- Predictive Value of Tests
- ROC Curve
- Sensitivity and Specificity
- alpha-Fetoproteins
(analysis)
|